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Abstract
Purpose Inter-individual variability in bone mineral density (BMD) exists within and between endurance runners and 
non-athletes, probably in part due to differing genetic profiles. Certainty is lacking, however, regarding which genetic vari-
ants may contribute to BMD in endurance runners and if specific genotypes are sensitive to environmental factors, such as 
mechanical loading via training.
Method Ten single-nucleotide polymorphisms (SNPs) were identified from previous genome-wide and/or candidate gene 
association studies that have a functional effect on bone physiology. The aims of this study were to investigate (1) associa-
tions between genotype at those 10 SNPs and bone phenotypes in high-level endurance runners, and (2) interactions between 
genotype and athlete status on bone phenotypes.
Results Female runners with P2RX7 rs3751143 AA genotype had 4% higher total-body BMD and 5% higher leg BMD 
than AC + CC genotypes. Male runners with WNT16 rs3801387 AA genotype had 14% lower lumbar spine BMD than AA 
genotype non-athletes, whilst AG + GG genotype runners also had 5% higher leg BMD than AG + GG genotype non-athletes.
Conclusion We report novel associations between P2RX7 rs3751143 genotype and BMD in female runners, whilst differ-
ences in BMD between male runners and non-athletes with the same WNT16 rs3801387 genotype existed, highlighting a 
potential genetic interaction with factors common in endurance runners, such as high levels of mechanical loading. These 
findings contribute to our knowledge of the genetic associations with BMD and improve our understanding of why some 
runners have lower BMD than others.
Keywords Genetics · Single-nucleotide polymorphisms · Bone mineral density · Endurance · Marathon · Mechanical 
loading
Abbreviations
ANOVA  Analysis of variance
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DXA  Dual-energy X-ray absorptiometry
GWAS  Genome-wide association study
SNP  Single nucleotide polymorphism
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Introduction
Individuals who complete higher levels of weight-bearing 
physical activity tend to have higher bone mineral den-
sity (BMD) (Warburton et al. 2006). Despite this, some 
athletes, such as endurance runners may be at risk of low 
BMD and increased risk of stress fracture injury, which 
negatively impacts both health and performance (Pollock 
et al. 2010). Excessive training volumes and/or dietary 
restriction undertaken by this population can result in 
reduced energy availability, which can negatively impact 
bone metabolism and potentially reduce BMD (Papageor-
giou et al. 2018).
Nonetheless, inter-individual variability in bone phe-
notypes exist, even within sport-specific cohorts (as dem-
onstrated in Part A), which may be explained in part by 
genetic factors. Heritability of BMD is reportedly 50–80% 
(Ralston and Uitterlinden 2010), with 98 loci having been 
associated with total, femoral neck and lumbar spine dual-
energy X-ray absorptiometry (DXA)-derived BMD previ-
ously (Trajanoska et al. 2019). Few investigations, have 
replicated these associations independently or considered 
gene-environment interactions (Trajanoska et al. 2019). It 
remains unclear whether certain genes may be sensitive 
to mechanical loading from physical activity and what the 
outcome is of such an interaction for BMD and injury risk 
(Herbert et al. 2019).
Mitchell et  al. (2016) investigated genomic compo-
nents of bone phenotypes and the relationship with physi-
cal activity using SNPs that had previously been asso-
ciated with BMD via GWAS (Estrada et al. 2012). The 
authors observed nominal interactions at the lumbar spine 
in children between physical activity and variants such 
as Wnt family member 16 (WNT16) rs3801387 and axin 
1 (AXIN1) rs9921222. In athletes competing in weight-
bearing sports specifically, higher total-body BMD was 
shown in the vitamin D receptor (VDR) FokI rs2228570 
GG and GA, but not AA, genotypes compared to non-ath-
lete controls (Nakamura et al. 2002b). Interestingly, within 
swimmers, a lower total BMD was observed in the GG 
genotype when compared to non-athlete controls (Naka-
mura et al. 2002b). Together, these findings suggest that 
individuals with the GG genotype may be more responsive 
to mechanical loading, resulting in greater BMD under 
conditions of high mechanical loading, but lower BMD 
when the mechanical loading is less, such as in swim-
ming. Thus, phenotypes can vary between individuals of 
the same genotype, especially when that genotype demon-
strates sensitivity to mechanical loading.
It is possible that athletes tend to possess advantageous 
variants of genes that are responsive to mechanical load-
ing and others that are important for the attainment of 
peak BMD. This may result in a competitive advantage 
via more consistent and higher volume training because 
of the higher BMD and subsequent reduced injury risk. 
Some endurance runners are at risk of reduced energy 
availability due to the potential undertaking of high train-
ing volumes and/or insufficient energy intake, which may 
negatively impact BMD. Consequently, possessing an 
advantageous genetic predisposition for BMD is likely to 
be of greater importance for the health and performance 
of populations at risk of low BMD, such as endurance 
runners, than athletic populations competing in sports 
that exhibit high peak and multi-directional forces on 
bone. Those who possess a more advantageous geno-
type may have a greater response to loading, resulting in 
higher BMD and a reduced risk of a stress fracture. The 
potential consequence of a disadvantageous genotype 
has been demonstrated in dancers, who are also at risk of 
low BMD. Specifically, genetic variants in the oestrogen 
receptor and the Wnt/β-catenin pathways were associated 
with an increased prevalence of low BMD in elite danc-
ers (Amorim et al. 2018). Moreover, the increased preva-
lence of low BMD in the dancers was not predicted by 
previously suggested risk factors of body mass, menstrual 
disturbances and energy availability. Thus, low BMD in 
the absence of known risk factors further emphasises the 
potential modulation of the BMD phenotype via genetic 
characteristics (Amorim et al. 2018).
Only a small number of BMD-associated genetic variants 
have been explored in athletic populations, or in relation to 
gene-physical activity interactions, so the genetic influence 
on BMD in athletic populations is still unknown. Endurance 
runners, in particular, experience high volumes of mechani-
cal loading at certain sites (e.g. tibia) but less loading at oth-
ers (e.g. lumbar spine). Despite experiencing high volumes 
of loading, some endurance runners may have low BMD 
and thus present a suitable population in which to inves-
tigate gene-physical activity interactions vis-à-vis BMD 
(Herbert et al. 2019). Variability as well as differences in 
bone phenotypes between high-level endurance runners and 
non-athletes are reported in Part A of this two-part investiga-
tion. The purpose of this second part was to (1) investigate 
whether the 10 SNPs, individually and collectively, associ-
ated with phenotypes including total-body BMD (TBMD), 
leg BMD (LBMD), lumbar spine BMD (LSBMD), total-body 
T-score and total-body Z-score in high-level endurance run-
ners; (2) investigate whether being an endurance runner or 
non-athlete affected any association between genotype and 
bone phenotypes. The 10 SNPs chosen for investigation all 
have reported functional effects on bone and have also been 
identified via genome-wide association study and/or candi-
date gene association study as being associated with BMD 
(Table 1). We hypothesised associations between genotype 
and bone phenotypes in high-level endurance runners, plus 
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the existence of genotype-athlete status interactions on bone 




Participants comprised 103 high-level endurance runners 
(45 men, 58 women) and 112 (52 men, 60 women) ethni-
cally matched non-athletes. Briefly, runners were included 
if they had completed at least one official long-distance 
event (≥ 3000 m) faster than a pre-determined threshold 
time (Table 1, Part A) and were considered national/inter-
national standard. Please see Part A for a full description of 
participant characteristics. All experimental procedures were 
conducted in accordance with the guidelines in the Declara-
tion of Helsinki and approved by the local Ethics Committee 
of Manchester Metropolitan University.
Protocol
All runners completed a questionnaire that detailed geo-
graphic ancestry, performance, training practices, injury 
and sporting history, whilst female runners also provided 
menstruation history. Non-athletes completed a question-
naire in relation to ethnicity, general health and physical 
activity level to establish matched ethnic ancestry and ensure 
no history of high-level sporting competition. DXA scans on 
all participants were completed following the manufacturer’s 
guidelines to obtain TBMD, LBMD, LSBMD, total-body T- 
and Z-scores.
All participants also provided either a blood, saliva or 
buccal swab sample, from which DNA was extracted and 
genotyped for the 10 SNPs, which were selected accord-
ing to the volume and strength of evidence in the literature 
of their association with BMD and/or biological function/
mechanism in relation to BMD (Table 1).
For blood, a 5 mL sample was collected from a superfi-
cial forearm vein into EDTA collection tubes and stored in 
1.5 mL microcentrifuge tubes (Eppendorf AG, Hamburg, 
Germany) at − 20 °C. Saliva samples were collected fol-
lowing a minimum 30-min abstinence from food and drink 
into Oragene DNA OG-500 collection tubes (DNA Gen-
otek Inc., Ontario, Canada) in accordance with the manufac-
turer’s guidelines before being stored at room temperature. 
For buccal cell sample collection, participants brushed one 
OmniSwab collection tip (Whatman Sterile OmniSwab, GE 
Healthcare, USA) against the inside of one cheek for 30 s 
before repeating this with a second swab on the opposite 
cheek to obtain two samples (following the same abstinence 
as saliva samples) before being stored at − 20 °C in a 2 mL 
microcentrifuge tube. DNA was extracted using the Qiagen 
QIAcube spin protocol (Qiagen, Crawley, UK) and the Qia-
gen DNA Blood Mini Kit (Qiagen) for whole blood, saliva 
and buccal samples in accordance with the manufacturer’s 
guidelines. Approximately 75% of participant DNA was 
obtained from blood, 23% from saliva and 2% via buccal 
swabs.
All participants were genotyped for the 10 SNPs using the 
fluorophore-based detection technique of TaqMan real-time 
polymerase chain reaction (PCR) on either the Fluidigm EP1 
(Fluidigm, Cambridge, UK) or StepOnePlus (Applied Bio-
systems, Paisley, UK). End-point fluorescence measurement 
of VIC and FAM determined the different genotypes for the 
10 SNPs using the software supplied by the respective man-
ufacturers of each PCR machine.
The majority of samples (95%) were genotyped via the 
Fluidigm EP1 by combining 2 μL GTXpress Master Mix 
(X2) (Applied Biosystems), 0.2 μL 20X Fast GT Sample 
Loading Reagent (Fluidigm), 0.2 μL nuclease-free  H2O and 
1.6 μL of purified DNA into each well of a 192 × 24 micro-
chip. Negative controls were placed into 4 wells on each 
192 × 24 microchip, in which nuclease-free  H2O replaced 
the DNA sample. 1.78 μL assay (20X) (Applied Biosys-
tems), 1.78 μL 2X Assay Loading Reagent (Fluidigm) and 
0.18 μL ROX reference dye (Invitrogen, Paisley, UK) were 
combined per assay inlet. An integrated fluid circuit con-
troller RX (Fluidigm) was used to mix samples and assays 
using a Load Mix (166X) script. PCR was performed using 
a real-time FC1 Cycler (Fluidigm) GT 192 × 24 Fast v1 
protocol. Denaturation began at 95 °C for 120 s followed by 
45 cycles of incubation at 95 °C for 2 s and then annealing 
and extension at 60 °C for 20 s before end-point analysis was 
completed in the EP1 reader. Genotyping was performed 
with the Fluidigm SNP genotyping analysis software.
The remaining 5% of samples were genotyped by combin-
ing 5 μL Genotyping Master Mix or GTXpress Master Mix 
(Applied Biosystems), 4.3 μL  H2O, 0.5 μL assay (Applied 
Biosystems), and 0.2 μL of purified DNA (~ 9 ng), for sam-
ples derived from blood and saliva into wells on a 96-well 
plate (MicroAmp EnduraPlate Optical 96-Well Clear Reac-
tion Plate, Applied Biosystems). For DNA taken from buccal 
swabs, 5 μL Genotyping Master Mix was combined with 
3.5 μL  H2O, 0.5 μL assay mix, and 1 μL DNA solution 
(~ 9 ng DNA). Negative controls were also placed into 2 
wells on each 96-well plate, in which nuclease-free  H2O 
replaced the DNA sample. Each well on a 96-well plate 
contained a total reaction volume of ~ 10 μL before being 
covered with an optical seal (MicroAmp Optical Adhesive 
Film, Applied Biosystems). PCR was performed using a Ste-
pOnePlus Real-Time PCR system (Applied Biosystems). For 
GTXpress Master Mix, an initial 20 s at 95 °C was followed 
by 50 cycles of denaturation for 3 s at 95 °C, then annealing 
and extension at 60 °C for 20 s. For Genotyping Master Mix, 
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denaturation began at 95 °C for 10 min, with 40 cycles of 
incubation at 92 °C for 15 s and then annealing and exten-
sion at 60 °C for 1 min. Genotyping analysis was performed 
with StepOnePlus software version 2.3.
All samples were analysed in duplicate and were in 100% 
agreement. Similarly, there was 100% agreement between 
the StepOnePlus and Fluidigm PCR systems as determined 
by the analysis of one variant on 94 samples.
Statistical analysis
Using additive (AA vs. Aa vs. aa), dominant (AA + Aa 
vs. aa) and recessive (AA vs. Aa + aa) genetic models for 
men and women separately, analysis of variance (ANOVA) 
was implemented to investigate associations between the 
10 SNPs individually, and collectively as a total genotype 
score (TGS), and bone phenotypes (TBMD, LBMD, LSBMD, 
T-score, Z-score) in runners. Recessive and dominant mod-
els were executed with respect to the allele considered dis-
advantageous for BMD. For TGS, each SNP was allocated 
scores according to existing literature (Williams and Folland 
2008), where the homozygote associated with higher BMD 
was given a score of 2, the heterozygotes scored 1 and the 
other homozygote given 0. The total score was then trans-
formed to lie within 0–100 (e.g. TGS = 100/20 × (2 + 1 + 0 
+ 1 + 1 + 1 + 0 + 2 + 1 + 2) = 55). Consequently, participants 
were allocated to either a “low” (≤ 55), “moderate” (60–70) 
or “high” (≥ 75) TGS group based upon calculated TGS 
score. Significant associations from any additive model were 
further explored using Bonferroni post-hoc tests. ANOVA 
was also used to explore interactions between the 10 SNPs, 
individually and collectively, and athlete status on bone phe-
notypes. Following any significant interaction between ath-
lete status and genotype for a bone phenotype, simple main 
effects with pairwise comparisons were conducted to ana-
lyse cohort-dependent differences in these bone phenotypes 
between runners and non-athletes across the same genotype. 
To control for Type 1 statistical errors from multiple testing, 
a false discovery rate (FDR) of 0.2 (Benjamini and Hochberg 
1995) was applied within each family of ANOVAs for each 
SNP and uncorrected P-values are reported except where 
stated. Consequently, two FDR models for each SNP (each 
including 15 P-values for every ANOVA implemented) were 
applied to both the analyses within the runners and the anal-
yses exploring the interactions between genotype and athlete 
status on bone phenotype. Due to an insufficient number of 
participants with two copies of the minor allele, COL1A1 
rs1800012 female analyses only included 5 P-values for 
each FDR model whilst LRP5 rs3736228 male analyses 
only included 10 P-values for one FDR model (interaction 
analyses). Alpha was set at 0.05 and data are reported as 
mean (SD).
Results
Participant characteristics and phenotype data for men and 
women are as described in Part A of this investigation.
Genetic associations in runners
In the dominant analysis model, female runners with P2RX7 
rs3751143 AA genotype had 4% higher TBMD (P = 0.052) 
and 5% higher LBMD (P = 0.036) than AC + CC geno-
type female runners but no differences were evident for 
LSBMD (P = 0.512) as shown in Fig. 1. Additionally, AA 
genotype female runners had a higher T-score (1.36 vs 0.81; 
P = 0.047) and Z-score (1.27 vs 0.70; P = 0.017) in compari-
son to AC + CC genotypes.
In the additive analysis model, a main effect of P2RX7 
rs3751143 genotype on TBMD (P = 0.016), LBMD 
(P = 0.080), T-score (P = 0.018) and Z-score (P = 0.013) but 
not LSBMD (P = 0.514) existed within the female runners. 
Following post-hoc analysis, those with AA genotype pos-
sessed 5% higher TBMD than AC genotypes (P = 0.036) but 
no difference was evident for LBMD (P = 0.077) as shown 
in Fig. 2. AA genotypes also had a higher T-score (1.36 
vs 0.64; P = 0.034) and Z-score (1.26 vs 0.57; P = 0.016) 
than AC genotypes. No genotype-dependent differences 
for P2RX7 rs3751143 on any bone phenotype were present 
within runners in the recessive analysis model (corrected 
P ≥ 0.288).
No other SNPs, individually or collectively as part of 
a TGS were associated with any bone phenotypes in men 
or women after multiple testing correction (corrected 
P ≥ 0.215; Figs. 3 and 4). 
Full results from analyses of genotype and bone pheno-
types in runners are provided in Tables 1 and 2 in supple-
mentary material.
Genotype‑cohort interactions
A genotype-cohort interaction was evident for WNT16 
rs3801387 and all bone phenotypes in men for both the 
additive (TBMD, P = 0.057; LBMD, P = 0.032; LSBMD, 
P = 0.042; T-score, P = 0.052 and Z-score, P = 0.045; 
Table 1 in Supplementary Material) and recessive analy-
sis models (TBMD, P = 0.020; LBMD, P = 0.009; LSBMD, 
P = 0.021; T-score, P = 0.040; Z-score, P = 0.015). Male 
runners with WNT16 rs3801387 AA genotype in compari-
son to their AA genotype non-athlete counterparts, had 
lower values for TBMD, T-score and Z-score (P ≤ 0.014), 
as well as LSBMD, where the largest difference was 
shown (14%; P < 0.001; Fig.  5). In addition, WNT16 
rs3801387 AG + GG genotypes had 5% higher LBMD than 
AG + GG non-athletes (P = 0.049). There were no other 
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genotype-cohort interactions in men, and no genotype-
cohort interactions in women.
Full genotype-cohort interaction results for the additive 
model are provided in Tables 1 and 2 in supplementary 
material.
Discussion
This study is the first to investigate bone phenotypes and 
BMD-associated genetic variants in high-level endur-
ance runners and non-athletes. We report novel associa-
tions between BMD and P2RX7 rs3751143 for high-level 
endurance runners whilst WNT16 rs3801387 demonstrated 
genotype-cohort differences in BMD between runners and 
non-athletes.
In female runners, P2RX7 rs3751143 AA genotypes had 
higher TBMD, LBMD, T-score and Z-score than AC + CC 
genotypes. Higher BMD in AA genotypes has been reported 
previously in non-athletes (Wesselius et al. 2013) whilst 
lower LSBMD has been shown in CC homozygote osteo-
porotic women (Husted et al. 2013). The P2RX7 rs3751143 
C-allele has been associated with osteoclast apoptosis 
(Ohlendorff et al. 2007) and reduced bone strength as well 
as stress fracture incidence in elite athletes (Varley et al. 
2016), which indicates that the loss-of-function C-allele 
may reduce BMD. This is the first study to investigate the 
association of P2RX7 rs3751143 on these bone phenotypes 
Fig. 1  Mean total bone mineral 
density (TBMD), leg bone min-
eral density (LBMD) and lum-
bar spine bone mineral density 
(LSBMD) according to P2RX7 
rs3751143 genotype, AA 
(n = 36) vs AC + CC (n = 22), 
in female high-level endurance 
runners. Higher TBMD and 
LBMD but not LSBMD in AA 
than AC + CC genotypes. Error 
bars denote standard deviation




















Fig. 2  Mean total bone mineral 
density (TBMD), leg bone 
mineral density (LBMD) and 
lumbar spine bone mineral 
density (LSBMD) according to 
P2RX7 rs3751143 genotype, 
AA (n = 36) vs AC (n = 19) vs 
CC (n = 3), in female high-level 
endurance runners. Higher 
TBMD but not LBMD in AA 
than AC genotypes. No dif-
ferences between genotypes 
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in an endurance runner cohort, suggesting that possessing 
a C allele may also negatively impact BMD, similarly to 
non-athletes. The differences we observed in measured bone 
phenotypes (except LSBMD) between AA and AC + CC 
genotypes in runners indicates that possessing the AA gen-
otype is beneficial for BMD, particularly at sites where a 
greater volume of mechanical loading is occurring. Con-
sequently, P2RX7 rs3751143 may have a greater influence 
on bone at certain points across the lifespan via interaction 
with mechanical loading and is thus particularly pertinent 
when enhancing bone mass in childhood or using exercise 
to combat BMD loss during ageing. Moreover, some SNPs 
may have a greater influence on particular bone components. 
For example, P2RX7 rs1718119 has been associated with 
cortical thickness whilst sclerostin (SOST) rs1877632 has 
been associated with trabecular density (Varley et al. 2018). 
Cortical and trabecular bone adaptation and loss occur at dif-
fering rates (Riggs et al. 2008) and thus genotype-dependent 
differences may influence these phenotypes distinctly.
No significant associations were observed for the 
TNFRSF11A rs3018362 or TNFRSF11B rs4355801 SNPs. 
Both SNPs are reported to influence bone metabolism 
and BMD within non-athlete populations (Richards et al. 
2008; Albagha et al. 2010) but appear unrelated to bone 
phenotypes within high-level endurance runners. Simi-
larly, AXIN1 rs9921222, COMT rs4680, LRP5 rs3736228 
and VDR rs2228570 genotypes did not differ for any bone 
phenotypes in the current study, but these observations are 
in contrast with previous literature that has shown poten-
tial gene-physical activity/mechanical loading interactions 
with BMD (Nakamura et al. 2002a; Mitchell et al. 2016). 
These contrasting findings may be due to inconsistencies 
Fig. 3  Mean total bone mineral 
density (TBMD), leg bone 
mineral density (LBMD) and 
lumbar spine bone mineral 
density (LSBMD) according 
to total genotype score (TGS) 
group, < 55 (n = 7) vs 60–70 
(n = 32) vs > 75 (n = 6), in male 
high-level endurance runners. 
No differences between groups 
defined by TGS for any bone 
phenotype in male runners. 

















Fig. 4  Mean total bone mineral 
density (TBMD), leg bone 
mineral density (LBMD) and 
lumbar spine bone mineral 
density (LSBMD) according 
to total genotype score (TGS) 
group, < 55 (n = 13) vs 60–70 
(n = 34) vs > 75 (n = 11), in 
female high-level endurance 
runners. No differences between 
groups defined by TGS for 
any bone phenotype in female 
runners. Numbers within bars 
are number of runners per TGS 
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in the measurement of physical activity used (e.g. question-
naires), as well as specific genotype-dependent differences in 
response to various types of mechanical loading. For exam-
ple, Nakamura et al. (2002a, b) investigated handball, volley-
ball and jumping athletes, all of whom require movements 
of high-impact loading and forces that are multi-directional 
in nature, and are thus very different from the lower impact 
and cyclical movements completed in endurance running. 
Consequently, the outcomes of potential gene-mechanical 
loading interactions may differ.
A genotype-cohort interaction was observed for WNT16 
rs3801387 and all bone phenotypes in men for both the 
additive and recessive analysis models. Male runners with 
AA genotype possessed lower TBMD, LSBMD, T-score and 
Z-score than AA genotype non-athletes, whilst AG + GG 
genotype runners had higher LBMD than their non-athlete 
counterparts. Interestingly, AA genotype was most advan-
tageous for BMD in non-athletes but most detrimental for 
runners, with higher values for all bone phenotypes observed 
in the AG + GG genotype group. Accordingly, the A allele 
has been previously associated with lower LSBMD, femoral 
neck BMD and osteoporotic fracture in non-athletes (Estrada 
et al. 2012). Furthermore, this SNP also interacts with physi-
cal activity and LSBMD in children (Mitchell et al. 2016). 
These findings suggest that possessing WNT16 rs3801387 
AA genotype may have a greater impact on BMD in runners 
than non-athletes, particularly at sites where less loading 
occurs. Wnt16 is a key regulator of osteoblast-to-osteoclast 
communication and targeted disruption of Wnt16 in mice 
results in a 27% loss in bone size and 43–61% loss in bone 
strength (Zheng et  al. 2012). Wnt16 expression is also 
reported to be influenced by oestrogen receptor signalling 
in a sex-specific manner with age in mouse tibia (Todd et al. 
2015). Oestrogen deficiency has been reported to decrease 
Wnt16 expression whilst oestrogen replacement increased 
Wnt16 expression in mouse cortical bone (Alam et al. 2017). 
Moreover, low oestradiol levels have been reported and asso-
ciated with reduced BMD in male endurance runners pre-
viously (Ackerman et al. 2012). Consequently, it could be 
hypothesised that interactions between WNT16 variants (and 
subsequent Wnt16 expression) and low oestradiol levels in 
male runners could negatively impact BMD.
No further genotype-cohort interactions for any bone phe-
notypes were observed in either men or women. The findings 
for TNFRSF11A rs3018362 and P2RX7 rs3751143 SNPs are 
therefore in agreement with Varley et al. (2018) who showed 
no genotype-by-time interactions on bone phenotypes fol-
lowing completion of a 12-week training programme in 
academy football players.
Conclusion
This study is the first to investigate bone phenotypes and 
BMD-associated genetic variants in high-level endurance 
runners and non-athletes. We report novel associations 
between P2RX7 rs3751143 genotype and BMD in female 
runners, whilst differences in BMD between male runners 
and non-athletes with the same WNT16 rs3801387 genotype 
existed, highlighting a potential genetic interaction with fac-
tors common in endurance runners, such as mechanical load-
ing. These findings contribute to our knowledge of genetic 
associations with BMD and improve our understanding 
of why some runners have lower BMD than others. Inde-
pendent replication plus identifying other relevant genetic 
variations could lead towards more personalised exercising 
programming, partly based upon genetic information, to 
Fig. 5  Mean lumbar spine bone 
mineral density (LSBMD) in 
male runners and non-athletes 
according to WNT16 rs3801387 
genotype (AA vs AG vs GG). 
Significant interaction between 
runner/non-athlete status and 
genotype (P = 0.042), with nota-
bly lower LSBMD in AA geno-
type runners than non-athletes 
(P < 0.001). Numbers within 
bars are number of runners per 
genotype group and error bars 
denote standard deviation




















AA AG GGP = 0.042
P = <0.001
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manage injury risk and thus improve health and performance 
in endurance runners.
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